Abstract Library

#4202 Preliminary experience with a new institutional dedicated neuroendocrine team in a tertiary

Introduction: Due to the complexity of neuroendocrine neoplasm (NEN) management, a multidisciplinary approach is strongly encouraged. At our institution, tertiary care center, a NEN Team was established in January 2021.

Conference:

Presenting Author: Smiroldo V

Authors: Smiroldo V, Bollina R, de Nucci G, Della Torre S,

Keywords: tertiary care center, multidisciplinary, NEN team,

#3890 Intracardiac metastasis in well-differentiated ileal neuroendocrine tumor

Introduction: About 60% of well-differentiated neuroendocrine tumors are diagnosed with metastatic disease, above all with liver involvement. The incidence of myocardial metastasis in patients with metastatic neuroendocrine tumor is less than 4%. These are mostly asymptomatic metastasis, so the diagnosis is often incidental.

Conference:

Presenting Author: Della Torre S

Authors: Della Torre S, Smiroldo V, Cozzi C, Galeassi A, Di Bella S,

Keywords: cardiac metastasis, neuroendocrine tumor,

#3247 The impact of COVID-19 pandemic on oncological care in neuroendocrine patients - A single-institution experience

Introduction: Since the first cases during the month of December 2019, coronavirus disease (COVID-19) evolved into a worldwide emergency. At the Humanitas Cancer Center, we have been operating at the epicenter of the European outbreak since the end of February, when the first Italian case was registered. Our government imposed a general lockdown from March to June in order to limit the spread of the infection across the population.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Smiroldo V

Authors: Smiroldo V, Zerbi A, Lavezzi E, Nappo G, Capretti G,

Keywords: covid-19, neuroendocrine tumor, telemedicine,

#2903 Bone Metastases (BM) in Neuroendocrine Tumors (NET): Imaging Characteristics and Clinical Implications. A Single-Institution Experience

Introduction: The incidence of BM in NET is underestimated and there is no consensus on clinical features, diagnostic techniques, and treatment options.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Smiroldo V

Authors: Smiroldo V, Lania A, Pedicini V, Pepe G, Zerbi A,

Keywords: bone metastases, skeletal related event, survival, bisphosphonates, 68Ga-PET, 18FDG-PET, CT scan,

#2247 Efficacy of Oral Chemotherapy with Capecitabine and Temozolomide (Captem) in Patients with Metastatic Neuroendocrine Tumors (NETS). A Single-Institution Experience

Introduction: CapTem chemotherapy regimen is a standard treatment for NETs but limited scientific data on its efficacy and tolerability are available

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Smiroldo V, Carnaghi C, Lania A, Bonifacio C, Pepe G,

Keywords: CapTem, metastatic neuroendocrine tumors,